What is Sunshine Biopharma Inc.'s Market Cap?

Sunshine Biopharma Inc.'s Market Cap is $4.5M, based on as-reported figures from SEC (XBRL) filings.

What is Sunshine Biopharma Inc.'s Enterprise Value?

Sunshine Biopharma Inc.'s Enterprise Value is -$9.3M, based on as-reported figures from SEC (XBRL) filings.

What is Sunshine Biopharma Inc.'s Price / Sales?

Sunshine Biopharma Inc.'s Price / Sales is 0.1×, based on as-reported figures from SEC (XBRL) filings.

What is Sunshine Biopharma Inc.'s EV / Revenue?

Sunshine Biopharma Inc.'s EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Sunshine Biopharma Inc.'s EV / EBITDA?

Sunshine Biopharma Inc.'s EV / EBITDA is 1.7×, based on as-reported figures from SEC (XBRL) filings.

What is Sunshine Biopharma Inc.'s Revenue (TTM)?

Sunshine Biopharma Inc.'s Revenue (TTM) is $35.3M, based on as-reported figures from SEC (XBRL) filings.

What is Sunshine Biopharma Inc.'s Net Income (TTM)?

Sunshine Biopharma Inc.'s Net Income (TTM) is -$5.8M, based on as-reported figures from SEC (XBRL) filings.

What is Sunshine Biopharma Inc.'s EBITDA?

Sunshine Biopharma Inc.'s EBITDA is -$5.5M, based on as-reported figures from SEC (XBRL) filings.

What is Sunshine Biopharma Inc.'s Diluted EPS (TTM)?

Sunshine Biopharma Inc.'s Diluted EPS (TTM) is -1.50, based on as-reported figures from SEC (XBRL) filings.

What is Sunshine Biopharma Inc.'s EBITDA Margin?

Sunshine Biopharma Inc.'s EBITDA Margin is -15.7%, based on as-reported figures from SEC (XBRL) filings.

Sunshine Biopharma Inc. (SBFM) Financial Statements

Sunshine Biopharma Inc.

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SVBT66

XNAS · usd

1.15▲ 0.01 (0.88%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close1.14

Day's Range1.14 – 1.24

52-Week Range0.25 – 3.05

Volume287.6K

Avg Volume982.6K

Share Statistics

Shares Outstanding

Employees50

ExchangeXNAS

Listed2007-08-09

Share count as of August 13, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Sunshine Biopharma Inc. (SBFM)

What is Sunshine Biopharma Inc.'s Market Cap?: Sunshine Biopharma Inc.'s Market Cap is $4.5M, based on as-reported figures from SEC (XBRL) filings.
What is Sunshine Biopharma Inc.'s Enterprise Value?: Sunshine Biopharma Inc.'s Enterprise Value is -$9.3M, based on as-reported figures from SEC (XBRL) filings.
What is Sunshine Biopharma Inc.'s Price / Sales?: Sunshine Biopharma Inc.'s Price / Sales is 0.1×, based on as-reported figures from SEC (XBRL) filings.
What is Sunshine Biopharma Inc.'s EV / Revenue?: Sunshine Biopharma Inc.'s EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Sunshine Biopharma Inc.'s EV / EBITDA?: Sunshine Biopharma Inc.'s EV / EBITDA is 1.7×, based on as-reported figures from SEC (XBRL) filings.
What is Sunshine Biopharma Inc.'s Revenue (TTM)?: Sunshine Biopharma Inc.'s Revenue (TTM) is $35.3M, based on as-reported figures from SEC (XBRL) filings.
What is Sunshine Biopharma Inc.'s Net Income (TTM)?: Sunshine Biopharma Inc.'s Net Income (TTM) is -$5.8M, based on as-reported figures from SEC (XBRL) filings.
What is Sunshine Biopharma Inc.'s EBITDA?: Sunshine Biopharma Inc.'s EBITDA is -$5.5M, based on as-reported figures from SEC (XBRL) filings.
What is Sunshine Biopharma Inc.'s Diluted EPS (TTM)?: Sunshine Biopharma Inc.'s Diluted EPS (TTM) is -1.50, based on as-reported figures from SEC (XBRL) filings.
What is Sunshine Biopharma Inc.'s EBITDA Margin?: Sunshine Biopharma Inc.'s EBITDA Margin is -15.7%, based on as-reported figures from SEC (XBRL) filings.